Vanguard Personalized Indexing Management
BSX icon

Vanguard Personalized Indexing Management’s Boston Scientific BSX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.67M Sell
203,062
-12,013
-6% -$652K 0.07% 228
2026
Q1 		$13.5M Sell
215,075
-650
-0.3% -$52K 0.13% 127
2025
Q4 		$20.6M Sell
215,725
-1,945
-0.9% -$191K 0.2% 75
2025
Q3 		$21.3M Buy
217,670
+760
+0.4% +$78.7K 0.22% 72
2025
Q2 		$23.3M Buy
216,910
+37,578
+21% +$3.8M 0.26% 56
2025
Q1 		$18.1M Buy
179,332
+14,554
+9% +$1.47M 0.27% 60
2024
Q4 		$14.7M Buy
164,778
+9,057
+6% +$797K 0.22% 68
2024
Q3 		$13M Buy
155,721
+10,897
+8% +$859K 0.21% 73
2024
Q2 		$11.1M Buy
144,824
+20,142
+16% +$1.47M 0.21% 74
2024
Q1 		$8.54M Buy
124,682
+8,903
+8% +$572K 0.18% 91
2023
Q4 		$6.69M Buy
115,779
+14,497
+14% +$774K 0.17% 99
2023
Q3 		$5.35M Buy
101,282
+2,333
+2% +$122K 0.16% 105
2023
Q2 		$5.35M Buy
98,949
+5,205
+6% +$272K 0.16% 102
2023
Q1 		$4.69M Buy
93,744
+4,439
+5% +$209K 0.16% 111
2022
Q4 		$4.13M Buy
89,305
+10,928
+14% +$473K 0.17% 109
2022
Q3 		$3.04M Buy
78,377
+8,031
+11% +$322K 0.14% 140
2022
Q2 		$2.62M Buy
70,346
+11,450
+19% +$466K 0.12% 158
2022
Q1 		$2.61M Buy
58,896
+20,604
+54% +$893K 0.13% 145
2021
Q4 		$1.63M Buy
38,292
+1,251
+3% +$52.6K 0.1% 218
2021
Q3 		$1.61M Buy
37,041
+4,697
+15% +$208K 0.14% 138
2021
Q2 		$1.38M Buy
32,344
+13,657
+73% +$575K 0.14% 145
2021
Q1 		$722K Buy
18,687
+5,181
+38% +$196K 0.11% 217
2020
Q4 		$486K Buy
13,506
+1,003
+8% +$36.1K 0.11% 226
2020
Q3 		$478K Buy
12,503
+5,464
+78% +$211K 0.13% 184
2020
Q2 		$247K Buy
+7,039
New +$253K 0.11% 245

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Personalized Indexing Management's BSX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Boston Scientific (BSX) stake by 5.6% in Q2 2026, selling an estimated $652K and leaving 203,062 shares worth $8.67M. The position accounts for 0.07% of the portfolio, ranked #228.

Vanguard Personalized Indexing Management first reported a position in BSX in Q2 2020 and has held it in 25 quarters since. The position peaked at $23.3M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vanguard Personalized Indexing Management held 203,062 shares of Boston Scientific worth $8.67M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 12,013 Boston Scientific shares in Q2 2026, an estimated $652K.
  • Boston Scientific made up 0.07% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #228 holding.
  • Vanguard Personalized Indexing Management first reported a position in Boston Scientific in Q2 2020 and has held it in 25 quarters since.
  • Vanguard Personalized Indexing Management's Boston Scientific position peaked at $23.3M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.